Jackson Square Capital’s Ascendis Pharma A/S ASND Stock Holding History

Jackson Square Capital’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,651	Closed	-$1.44M	–	143
2024 Q3	$1.44M	Buy	+9,651	New	+$1.3M	0.36%	55
2021 Q1	–	Sell	-2,128	Closed	-$355K	–	167
2020 Q4	$355K	Hold	2,128	–	–	0.14%	111
2020 Q3	$328K	Sell	2,128 -458	-18%	-$65.8K	0.14%	96
2020 Q2	$382K	Buy	2,586 +1,615	+166%	+$222K	0.19%	77
2020 Q1	$109K	Buy	971 +416	+75%	+$54.1K	0.08%	92
2019 Q4	$77K	Buy	+555	New	+$61.7K	0.04%	132

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Jackson Square Capital's ASND Position: Q4 2024 in Review

Jackson Square Capital sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 9,651 shares — an estimated $1.44M sold.

Jackson Square Capital first reported a position in ASND in Q4 2019 and held it in 6 quarters. The position peaked at $1.44M in Q3 2024. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.

Jackson Square Capital reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
Jackson Square Capital sold 9,651 Ascendis Pharma A/S shares in Q4 2024, an estimated $1.44M.
Jackson Square Capital first reported a position in Ascendis Pharma A/S in Q4 2019 and held it in 6 quarters.
Jackson Square Capital's Ascendis Pharma A/S position peaked at $1.44M in Q3 2024.
214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.

Based on Jackson Square Capital's 13F filing for Q4 2024, filed 15 Jan 2025.